Adverum Biotechnlogies Inc (NASDAQ:ADVM)

Adverum Biotechnlogies Inc (NASDAQ:ADVM)


Share Price
$ 14.13
Change
0.36 (2.61 %)
Market Cap
$897.40 m
Proactive Investors - Run By Investors For Investors

Adverum Biotechnlogies Inc

Adverum Biotechnologies Inc (ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases.

EPIC: ADVM
Market: NASDAQ:ADVM
52-week High/Low: $16.380 / $2.620
Sector: Pharmaceuticals
Market Cap: $897.40 m
col 3
col 4
col 5
col 6

Adverum Biotechnlogies Inc Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use